Trial
NCT00014443
Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rush University Medical Center
Collaborators
—
Condition
Brain and Central Nervous System Tumors
Intervention
thalidomide
Why stopped
Poor enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-09